Jason Kent


I build long-term relationships with my clients, guiding them through all stages of development, from startup to IPO and beyond.

Jason Kent is co-chair of Cooley's public companies practice, and an experienced corporate and securities lawyer who has spent close to 25 years working with public and private companies on a wide range of transactional and counseling related matters. For his public company clients, Jason handles public offerings and other complex securities transactions, Board and corporate governance advice, SEC reporting and disclosure issues and compliance matters. In addition, Jason is an expert in venture financings, mergers and acquisitions, employment and compensation arrangements and founder and shareholder matters, and he regularly acts as the outside corporate counsel for his clients. Jason prides himself on the ability to deliver highly sophisticated advice in a pragmatic, business-oriented way that advances his clients' objectives. He is deeply committed to client service and strives to build long-term trusted relationships with the companies he represents, many of which he has worked with for well over a decade.

Download full bio 


  • Mirum Pharmaceuticals – $92 Million Follow-on Offering 

  • Travere Therapeutics – $316 Million Convertible Note Offering 

  • Vuori Secures $400 Million Investment From SoftBank Vision Fund 2 

  • Reneo Pharmaceuticals – $94 Million IPO 

  • Mirum Inks $210 Million Funding Arrangement + Closes Follow-On Offering 

  • View all


  • Stanford Law School
    JD, with distinction, Order of the Coif

  • Claremont McKenna College
    BA, Economics and Accounting, summa cum laude

Admissions & Credentials

New York




  • American Bar Association